1981
DOI: 10.1016/s0190-9622(81)70086-0
|View full text |Cite
|
Sign up to set email alerts
|

Actinic prurigo

Abstract: Actinic prurigo is a chronic photodermatitis found predominantly in North American Indians. Other terms have been used to describe similar cases in Central and South America and in Europe. Relatively little has been written about this condition in the English literature, and confusion exists over whether this is a form of polymorphic light eruption. Actinic prurigo can be considered a unique variant of polymorphic light eruption; however, we believe that certain differences help to distinguish actinic prurigo … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
6
0

Year Published

1983
1983
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(7 citation statements)
references
References 13 publications
1
6
0
Order By: Relevance
“…Covered areas were also affected in 8 of our patients (72%). This concurred with previous reports elsewhere (2,6,15,16). Only 2 patients (18%) had cheilitis.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Covered areas were also affected in 8 of our patients (72%). This concurred with previous reports elsewhere (2,6,15,16). Only 2 patients (18%) had cheilitis.…”
Section: Discussionsupporting
confidence: 93%
“…Actinic prurigo (AP) is reported as a rare familial photodermatosis which mostly affects young girls (1)(2)(3). AP was previously considered as a unique variant of polymorphic light eruption (PMLE), but recently it has been described as a different entity, which has characteristic geographic and racial distribution, as well as genetic susceptibility (4).…”
mentioning
confidence: 99%
“…Characteristic clinical features include prurigo-like papules, cheilitis and conjunctivitis with pseudopterigium formation. However, pruritus is the predominant symptom which is usually noted at early phases of the disease [19]. AP is often refractory to therapy, although topical, intralesional or systemic steroids [6], psoralen plus ultraviolet A [20], azathioprine [2], cyclosporine [8]and thalidomide [9]have been used with variable results.…”
Section: Commentmentioning
confidence: 99%
“…In our experience, the use of antimalarial drugs on a seasonal basis combined with monitoring for adverse effects was considered for recalcitrant cases, but was rarely of much clinical benefit. The prescription of β‐carotene as a photoprotective agent has also had limited success 21,24 . The use in low doses compared with previous reports 21,24 may account for its lack of success as a photoprotective agent in this series.…”
Section: Discussionmentioning
confidence: 84%